Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07647250 · ClinicalTrials.gov registry record · NA
Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
A NA study, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07647250 is a NA study that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 25 participants.
The verdict
NCT07647250, a NA study, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
Interventions
- OTHER 36-session targeted physical exercise program delivered twice weekly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-06-22 |
| Est. Completion | 2032-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07647250
The ClinicalTrials.gov registry entry for NCT07647250 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 36-session targeted physical exercise program delivered twice weekly is the first listed.
NCT07647250 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07647250 about?
NCT07647250 is a clinical study titled "Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy". Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
What is the current status of trial NCT07647250?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-06-22. Estimated completion is 2032-04-30.
What interventions are being tested in trial NCT07647250?
The interventions under investigation include: 36-session targeted physical exercise program delivered twice weekly (OTHER).
Who is sponsoring clinical trial NCT07647250?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.